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Abstract.  To examine the ultrastructural  distribution 
of laminin  within kidney basement membranes,  we 
prepared rat anti-mouse laminin  mAbs to use in im- 
munolocalization experiments.  Epitope domains for 
these mAbs were established by immunoprecipitation, 
immunoblotting,  affinity chromatography,  and rotary 
shadow EM.  One mAb bound to the laminin A  and B 
chains on blots and was located to a  site •15  nm from 
the long arm-terminal  globular domain as shown by 
rotary shadowing.  Conjugates of this long arm-specific 
mAb were coupled to horseradish peroxidase (HRP) 
and intravenously injected into mice. Kidney cortices 
were fixed for microscopy 3 h after injection.  HRP 
reaction product was localized irregularly  within the 
renal glomerular basement membrane (GBM) and 
throughout mesangial matrices.  In addition,  this rnAb 
bound in linear patterns specifically to the laminae 
rarae of basement membranes of Bowman's capsule 
and proximal tubule. This indicates the presence of the 
long arm immediately beneath epithelial cells in these 
sites.  The laminae densae of these basement mem- 
branes were negative by this protocol. In contrast,  the 
lamina ram and densa of distal tubular basement mem- 
branes (TBM) were both heavily labeled with this 
mAb. A  different ultrastructural  binding pattern was 
seen with eight other mAbs, including two that 
mapped to different situs on the short arms by rotary 
shadowing and five that blotted to a large pepsin- 
resistant laminin  fragment (P1).  These latter mAbs 
bound weakly or not at all to GBM but all bound 
throughout mesangial matrices.  In contrast,  discrete 
spots of HRP reaction product were seen across all 
layers of Bowman's capsule BM and proximal TBM. 
These same mAbs, however, bound densely across the 
full width of distal TBM. Our findings therefore show 
that separate strata of different basement membranes 
are variably immunoreactive to these laminin  mAbs. 
The molecular orientation or integration of laminin 
into the three dimensional BM meshwork therefore 
varies with location.  Alternatively,  there may be a 
family of distinct laminin-like  molecules distributed 
within basement membranes. 
ASEMENT membranes underlie epithelial cells and sur- 
round all muscle cells, Schwann cells of peripheral 
nerves,  and  fat  cells.  These  widespread  sheets  of 
extraeellular  matrix define tissue boundaries and represent 
barriers  to the passage of metastatic  and  other cells and 
macromolecules between tissue compartments.  In addition, 
basement membranes orient attached cells and are important 
for pattern development during organogenesis and wound re- 
pair  (reviewed  in references  2  and 60).  Ultrastructurally, 
basement membranes resemble a finely granular  mat of nar- 
row fibers that classically have been described as having two 
layers: (a) an electron lucent layer (lamina lucida or rara) im- 
mediately beneath the cells they are supporting and (b) a sub- 
jacent electron dense layer (lamina densa).  Some reports on 
freeze-substituted  tissues,  however, have failed to identify a 
lamina lucida, thus raising questions as to whether this layer 
might  be a  fixation  artifact  (20).  Nevertheless,  basement 
membranes are certainly polarized in the sense that their up- 
per surfaces contact cells and their lower surfaces face and 
are attached  to the underlying  interstitial  connective tissue. 
Considerable progress has been made in recent years in 
understanding  the molecular composition of basement mem- 
branes and cDNAs for the major structural  glycoproteins, 
collagen type IV and laminin, have now been cloned and par- 
tially  sequenced (7, 8,  13, 24, 30, 44, 49, 50, 53-55, 58). 
When viewed in the electron microscope, laminin is shaped 
as an asymmetric cross with three short arms and one long 
arm, all terminating  in globular domains (16). The molecule 
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Englebreth-Holm-Swarm tumor matrix is composed of three 
different  polypeptide chains designated A, B1, and B2 having 
a  combined molecular mass of ,'-,850,000 D  (26,  53-55). 
Most evidence now indicates that each short arm is formed 
by the NH2 terminus region of one of the polypeptides and 
that the center of the cross is where the three chains become 
associated through numerous disulfide bonds (reviewed in 
reference 40).  The long arm contains COOH-terminal re- 
gions of all three chains wound together in a coiled coil (7, 
48). Fragments oflaminin  have been obtained after treatment 
with various proteases and several  functional domains have 
been  identified.  Digestion  with  pancreatic  elastase  (46) 
yields, among some smaller products, a  140,000 Mr, piece 
of laminin corresponding to the end of the long arm includ- 
ing the terminal globule (48). This fragment, designated E8, 
has been shown to bind heparin and heparan sulfate pro- 
teoglycans and promote neurite outgrowth in vitro (13, 15, 
17, 40).  Pepsin treatment yields a  large, enzyme-resistant 
fragment designated P1 (52, 62). This three-armed structure 
lacks the globular domains seen in intact laminin and corre- 
sponds to the center of  the laminin cross (16, 52). In addition, 
the P1  fragment contains cell-binding activities for certain 
cells in culture (61). The ends of the arms of intact laminin 
are believed to bind specifically to collagen type IV and pos- 
sibly to other laminin molecules (9,  10,  64).  Laminin is 
therefore considered to be a cell attachment glycoprotein as 
well as a major structural element of basement membranes. 
Despite recent advances, however,  we do not yet under- 
stand the architecture of  basement membranes at the molecu- 
lar level. One approach to this problem has been to attempt 
to reconstruct basement membranes in vitro by admixing 
various preparations of purified basement membrane com- 
ponents. Based on electron microscopy of rotary shadowed 
replicas of such mixtures, several  models have been pro- 
posed (35, 65). Although they differ in detail, most models 
describe a core, three-dimensional meshwork of polymer- 
ized collagen type IV decorated systematically with laminin 
and heparan sulfate proteoglycans which themselves assume 
specific orientations. Another approach has been to label tis- 
sues immunohistochemieally  with antibodies specific for the 
various basement membrane components. Most results now 
indicate that collagen IV, laminin, heparan sulfate proteogly- 
cans, and entactin/nidogen are present throughout the full 
width of basement membranes (2,  3,  36,  60).  These im- 
munohistochemical results are consistent with what is known 
about the structure of laminin. When considering the size of 
the fully extended molecule (110 nm across the long axis × 
70 nm across the short arms [16]), laminin in an elongated 
conformation is clearly large enough to span basement mem- 
branes, most of which are 50-100 nm thick. There is little 
information, however, on the spatial configurations of lami- 
nin or any of the other basement membrane macromolecules 
in vivo. 
The purpose of the experiments described here was to pre- 
pare and characterize mAbs against different structural do- 
mains of laminin. We then used these mAbs in conjunction 
with immunoelectron microscopy to determine the  ultra- 
structural distribution of these laminin domains within base- 
ment membranes. 
Materials and Methods 
Enzymatic Digestion of  Laminin 
Laminin was purified from the mouse Englebreth-Holm-Swarm tumor by 
sequential  salt extraction, DEAE chromatography,  and gel filtration using 
a modification of the method originally reported by Timpl et al. (62) as pre- 
viously described (5). 
At a  concentration of 0.45  mg/ml  in  10%  acetic acid,  laminin was 
digested with porcine stomach pepsin (3,200 U/mg; Sigma Chemical Co., 
St. Louis, MO) at an enzyme/substrate ratio of 1:40 (wt/wt) for 16 h at 4°C. 
The reaction was stopped by dialysis  into PBS, pH 7.3. The pepsin digest 
was then chromatographer over a column of Sephacryl  S-300 (Pharmacia 
Fine Chemicals, Piscataway, N  J) to separate  the PI fragment. 
For elastase digestion, 0.45 mg/ml laminin in 0.05 M ammonium bicar- 
honate, pH 7.8, was treated with porcine pancreatic elastase  (127 U/mg; 
Serva Fine Biochemicals,  Westbury,  NY) at an enzyme/substrate ratio of 
1:500 (wt/wt) for 4 h at 37°C. The reaction was terminated by the addition 
of PMSF to a final concentration  of  0.2 M. In some cases, the elastase digest 
was  further processed by passage  over a  column of heparin-Sepharose 
(Pharmacia Fine Chemicals). Bound protein was eluted with the addition 
of 0.5 M NaCI in 0.05 M ammonium bicarbonate, pH 7.8. 
Production of  Rat Anti-Laminin mAbs 
A Sprague-Dawley  rat was immunized according to previously  published 
procedures (39) with slight modifications.  The rat received injections of 200 
t~g of purified laminin emulsified with an equal volume of  complete Freund's 
adjuvant, distributing the antigen subcutaneously  into the rear footpads and 
inguinal region. Injections of antigen in saline were repeated  four times at 
3-d intervals.  1 d after the last immunization, popliteal and inguinal lymph 
nodes were removed, prepared as a cell suspension, and fused with the non- 
secreting mouse myeloma cell line P3X63AB.653 as described (33). 14 d af- 
ter fusion, tissue culture supernatants were screened by ELISA on laminin- 
coated microtiter plates and those that were positive were screened further 
by  indirect immunofluorescence  on cryostat sections of mouse kidney. 
Clones that were intensely positive by both assays were subcioned by limit- 
ing dilution, expanded to high density,  and injected  into pristane-primed 
nude mice to produce ascites fluid, mAb subclass identity was established 
by ELISA using Ig-subclass  specific antibodies (Southern Biological  As- 
sociates,  Birmingham, AL). 
Characterization of  Monoclonal Anti-Laminin lgGs 
Immunoglobulins from ascites fluids were twice precipitated  with the addi- 
tion of equal volumes of saturated ammonium sulfate, pH 7.8, resuspended 
in 0.02 M phosphate, pH 7.3, and dialyzed  extensively  against the same 
buffer, lgGs were then obtained by chromatography over Whatman DE52 
anion exchange  cellulose (Pierce Chemical Co.,  Rockford,  IL) and all- 
quoted and stored at -20°C. Affinities of the separate mAbs for laminin 
were evaluated  in inhibition ELISAs  as described before  for polyclonal 
anti-taminin IgGs (1). 
lmmunoprecipitation of  Laminin 
Murine PYS-2 cells (37),  at a  density of 0.5  x  106/35 nun dish, were 
plated overnight in DME (Mediatech, Inc., Herndon, VA) containing 10% 
FCS  (Flow  Laboratories,  McLean,  VA). Confluent  monolayers  were 
washed  16 h later with serum-free methionine-depleted DME (1 pg/ml), 
either with or without 10/~g/ml tunicamycin  (Boehringer Mannheim Bio- 
chemicals, Indianapolis, IN). The cells were then incubated with 150 izCi/ 
dish of [35S]methionine (1,086 Ci/mmol) (Du Pont NEN Research  Prod- 
ucts, Boston, MA) in 1.0 ml DME containing 1 ~g/ml unlabeled methio- 
nine, with or without I0/~g/nd tunicaraycin for 1 h at 37°C. The monolayers 
were then washed three times with warm PBS and lysed with the addition 
of 450 ~l/dish lysis buffer (0.4 M NaCl, 0.01 M Tris-HCl, pH 8.0, 5 mM 
EDTA, 0.2 mM PMSF, 5 mM N-ethylmaleimide,  1% NP-40, and 0.02% so- 
dium azide). 
To prepare immunoadsorbents, a series of tubes each containing 2-3 mg 
protein A-Sepharose 4B (Pharmacia Fine Chemicals) were each mixed with 
25 /~1 rabbit anti-rat IgG (Fc  fragment specific;  Nordic Immunological 
Labs, Capistrano Beach, CA) in immunoprecipitation  buffer (0.15 M NaCl, 
0.01 M Tris-HCl, pH 8.0, 5 mM EDTA,  1% NF-40, 0.02% sodium azide). 
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times with immunoprecipitation buffer and then incubated overnight at 4°C 
with  unlabeled  parietal  yolk  sac  (PYS)-2  cell  lysate.  Beads  were  then 
washed with immunoprecipitation  buffer and then individual tubes were 
mixed with 25 #1 of  3-6 mg/ml of  one of  the rat monoclonal or control IgGs 
for 90 rain at room temperature. Alter three washes with immunoprecipita- 
tion buffer, tubes were then incubated for 90 rain at room temperature with 
one of the radiolabeled PYS-2 cell lysates. Beads were washed three times 
with a mixture of 1.0 ml immunoprecipitation  buffer and 450/~1 of lysis 
buffer and finally with two washes of  0.01 M Tris-HCI, pH 6.8. Beads were 
then boiled in SDS sample buffer containing DTT. After cooling, samples 
were aikylated with 0.5 M iodoacetamide and electrophoresed in SDS gels 
with a 5-15%  gradient of polyacrylamide (11). Coomassie brilliant blue- 
stained gels were soaked in Enlightning (Du Pont NEN Research Products) 
for 15 min before drying. Dried gels were then exposed to Kodak X-Omat 
(Eastman Kodak Co., Rochester, NY) film for 4-7 d at -70°C. Films were 
developed in Kodak D-19. 
Immunoblotting Analysis 
Nitrocellulose sheets onto which unreduced or reduced laminin had been 
electrotransferred  from polyacrylamide gels were blocked with 5%  solu- 
tions of nonfat powdered milk in PBS (BLOTTO [31]) and then sandwiched 
into a  miniblotter  apparatus  (Immunetics,  Cambridge,  MA).  Slots were 
treated sequentially with the rat monoclonal IgG fractions (100/~g/ml in 
BLOTTO) and affinity-purified goat anti-rat IgG coupled to horseradish per- 
oxidase (HRP) I (Organon-Teknika-Cappel, Malvern,  PA). Nitrocellulose 
sheets were then developed for peroxidase activity in 0.05% diaminobenzi- 
dine and 0.01% hydrogen peroxide (freshly diluted from a newly opened bot- 
tle of 30% H2Oz) in 0.1 M phosphate buffer (23), pH 6.0. Electroblots of 
unrednced luminin P1 and unreduced elastase-digested laminin were also 
probed with rat mAbs. 
AJfflnity Chromatography 
Affinity columns were prepared by mixing 5 mg of anti-laminin mAb 5A2, 
5C1, or 5D3 IgG with 3.0 ml of cyanogen bromide-activated  Sepharose 4B 
(Pharmacia Fine Chemicals) in 0.1 M NaHCOa, pH 8.3, containing 0.5 M 
NaCI for 2 h at room temperature. After washing with carbonate buffer, un- 
reacted sites were blocked with 0.2 M glycine in carbonate buffer for 2 h. 
The coupled gels were then washed twice with carbonate buffer, once with 
0.5 M NaCI in 0.1 M sodium acetate, pH 4.0, and finally resuspended in 
PBS containing 0.05 % sodium azide and stored at 4°C. Approximately 3-4 
mg elastase- or pepsin-digested laminin was passed over each column and 
bound fragments were eluted with 3 M potassium thiocyanate in 0.05 M 
phosphate buffer, pH 6.0. Eluted protein was dialyzed into either PBS, pH 
7.3 or 0.2 M ammonium bicarbonate,  pH 7.8. 
Rotary Shadowing of  Laminin and Monocional 
Anti-Laminin lgG Complexes 
Mixtures containing undigested laminin, iaminin PI, or elastase-generated 
laminin fragments (at concentrations of  0.1 #g/ml) and the mAbs (at concen- 
trations of  50 #g/ml) were dialyzed against several changes of  0.2 M ammo- 
nium bicarbonate. Samples were mixed with equal volumes of glycerol and 
sprayed onto sheets of freshly  cloven mica.  The  mica was then  rotary 
shadowed with platinum at an angle of 9  ° and carbon at an angle of 90  ° 
in a vacuum coater (model E306A; Edwards High Vacuum, West Sussex, 
UK) operated at  1 x  10  -~ Tort.  Replicas were removed by floating onto 
distilled water, picked up on 400-mesh copper grids,  and examined in a 
JEOL JEM-100 CX (JEOL USA, Peabody, MA) or Hitachi H-7000 (Hitachi 
Ltd., Tokyo) electron microscope. 
lmmunohistalogical Localization of the Anti-Laminin 
mAbs on Basement Membranes 
Immunofluorescence  Microscopy. A variety of  unfixed tissue samples from 
1. Abbreviations used in this paper:  GBM,  glomerular  basement, mem- 
brane; HRP, horseradish peroxidase; mAb-LA, mAb binding to the end of 
the long arm of laminin; mAb-SAh and mAb SA2, monoclonal antibodies 
binding to the short arms of laminin; parietal yolk sac; TBM, tubular base- 
ment membrane. 
mice were snap-frozen in isopentane chilled in a bath of  dry ice and acetone 
and 4-/zm-thick sections were cut at -20°C in a cryostat. Sections were air- 
dried at room temperature and then incubated sequentially with 50 #l/ml 
of one of the mAbs for 3-5 rain followed by FITC-conjugated goat anti-rat 
lgG (Organon-Teknika-Cappel). Slides were examined by epifluorescence 
in a Leitz Orthoplan photomicmscope. In some cases, sections were treated 
for 5 min with 0.1 M acetic acid, 0.05 U/ml chrondroitinase ABC, or 1 m 
U/ml  heparinase  and  1 m  U/ml  heparitinase  (ICN  Biomedicals,  Costa 
Mesa, CA) before immunolabeling. To screen the effects of  fixation on bind- 
ing of the mAbs, sections from mouse kidneys fixed with various dilutions 
of formaldehyde (freshly prepared from paraformaldehyde) and those fixed 
with paraformaldehyde-lysine-periodate (42) were also treated with mAbs 
and examined. In some experiments,  1.5-2.0 mg of the mAbs, in 0.02 M 
phosphate buffer, were intravenously injected via the saphenous vein into 
ether-anesthetized  mice. At  1-3 h after injection,  unfixed tissue samples 
were removed,  frozen,  and  sectioned.  In these cases,  sections were in- 
cubated only with FITC-conjugated anti-rat IgG before examination. 
lmmunoperoxidase Electron Microscopy. Each mAb was coupled directly 
to activated HRP (Type VI, Sigma Chemical Co.) following the procedure 
of Nakane and Kawaoi (43). The conjugates were then screened for spe- 
cificity on unfixed mouse kidney sections by immunofluorescence micros- 
copy as described above. Each anti-laminin monoclonal mAb-HRP con- 
jugate (at IgG concentrations of 2.0 mg/ml) was injected into at least two 
mice. 3 h after injection, kidneys were fixed by the subcapsnlar injection 
of 1.69[ paraformaldehyde and 3 % glutaraidehyde in 0.1 M sodium cacodyl- 
ate buffer, pH 7.4 (Karnovsky's fixative). 40-#m-thick tissue slices were ob- 
tained with a Vibratome (Ted Pella, Inc., Redding, CA) and then processed 
for peroxidase histochemistry using the same conditions as for immunoblot- 
ting.  Tissue was refixed for 2  h  in 2%  osmium  tetraoxide,  dehydrated, 
and embedded in epoxy. Ultrathin sections were stained for 30 s with lead 
citrate (51). 
Results 
Specificity of the Anti-Laminin IgOs 
Of the 216 rat-mouse hybridomas screened, 19 were intense- 
ly positive by ELISA on laminin-coated wells and by im- 
munofluorescence on mouse kidney basement membranes. 
Nine stable cell lines were eventually obtained through clon- 
ing that remained intensely positive by both of the above 
criteria. Isotyping showed that all of the clones were .secret- 
ing rat IgG1,  kappa.  Specificity for laminin was initially 
demonstrated by inhibition ELISAs and binding of 0.5 #g/ml 
monoclonal rat IgG to laminin-coated microtiter plates was 
diminished 50%  by preincubating the mAbs with soluble 
laminin at concentrations ranging from <l #g/ml up to 25 
#g/ml. 
Specificity was further confirmed by immunoprecipitation 
of metabolically labeled laminin from PYS cell culture ly- 
sates. As shown in Fig.  1, all of the antibodies precipitated 
laminin specifically.  Laminin A and B chains were recog- 
nized by all of the mAbs except 5A2, which precipitated only 
laminin B chains (Fig. 1). Binding was not eliminated in im- 
munoprecipitation  experiments  from  tunicamycin-treated 
PYS cultures (Fig.  1). Under these conditions, the A chain 
migrated faster and the B chains formed tighter bands in our 
gel system, indicating the efficacy of tunicamycin in at least 
reducing the amount of glycosylation. We were unable to 
clearly distinguish laminin B1 and B2 chains, however,  on 
autoradiograms of  tunicamycin-treated or untreated cultures. 
Control rat IgG did not precipitate any labeled PYS  cell 
products. 
Epitope Localization for the Anti-Laminin mAbs 
All nine of the mAbs bound to unreduced tumor laminin on 
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tured PYS cells. With the exception of mAb 5A2, all mAbs bind laminin A and B chains synthesized by cells in the absence of tunicamycin 
(-) and most also bind both chains in the presence  of the drug (+). 
Figure 2. Immunoblots of laminin electrotransferred to nitrocellu- 
lose after SDS-PAGE  under nonreducing (top) or reducing (bottom) 
conditions. (Top) All mAbs bind unreduced laminin (arrowhead). 
(Bottom) Three mAbs bind to reduced laminin.  Locations of the 
laminin A and B chains are shown on the left. A, mAb 3A4; B, 5A2; 
C, 5Cl; D, 5D3; E, 6D6; F,, 8B3; G, 8D3; H, 9B5; I, 9D2; J, con- 
trol rat IgG. 
electroblots (Fig. 2) and three also bound to reduced laminin 
(Fig. 2). mAbs 5A2 and 9D2 bound to the B chains and what 
appeared to be proteolytic fragments thereof, whereas 5D3 
bound to both A  and B  chains. 
To localize the epitopes further, laminin was treated with 
pepsin and the  P1  fragment was purified by gel  filtration. 
mAbs 3A4,  5C1,  8B3,  8D3,  and 9B5  bound to unreduced 
P1 on immunoblots (Fig.  3).  Similarly, products from con- 
trolled elastase digestion of laminin (Fig. 4) were probed on 
immunoblots with the mAbs. Only mAb 5D3, which did not 
bind P1, bound to a ,x,140-kD  (E8) fragment (Fig. 4, lane 4). 
Although mAbs 5A2 and 9D2 did not bind to E8 or P1  on 
immunoblots, they did react with some other laminin frag- 
ments present in the crude elastase digest (Fig. 4, lanes 5 and 
6). When these fragments were isolated by mAb 5A2 affinity 
chromatography,  however,  mAb  5D3  did  not  cross-react 
with them (Fig. 4,  lane  7). 
EM of rotary-shadowed immune complexes consisting of 
laminin and the mAbs allowed us to visualize directly some 
of the antibody binding sites, mAb 5A2 bound to a  site on 
the inner globule of the short arms of intact laminin (Fig. 5). 
The distance from the center of the laminin cross to point of 
contact with mAb 5A2 measured 20.2 nm (+0.7  nm, n  = 
34).  When  the  crude  elastase  digest  was  passed over an 
affinity column of mAb-5A2-Sepharose, large three-armed 
fragments  containing  globular  domains  were  eluted  with 
KSCN.  As seen with intact laminin,  mAb 5A2 also bound 
to an internal globule on the short arms of these fragments 
which measured 19.3 nm (+0.9 nm, n  =  17) from the center 
of the cross (Fig.  5).  mAb 5C1  bound to the lateral short 
arms near the center of the intact laminin cross (Fig. 6) and 
the same was true when 5C1 was mixed with purified P1 frag- 
ments (Fig. 6).  These sites measured  18.1 nm (+1.0 nm, n 
=  19) from the center of the cross of intact laminin and 17.3 
nm (+0.8 nm, n  =  24) on P1 fragments. In contrast, mAb 
5D3 bound  14.4 nm (+0.6 nm, n  =  19) from the terminal 
globular domain on the long arm (Fig. 7). In addition, 5D3 
also bound to a  site 14.4 nm (+0.6 nm, n  =  19)  from the 
globular domain on purified E8 fragments of laminin eluted 
from a 5D3 affinity column (Fig. 7) and to the same sites on 
those eluted from heparin-Sepharose. 
Antibody binding sites on the laminin molecule for the re- 
maining six mAbs were not clearly resolved with the rotary 
shadowing technique. For some of these mAbs, our observa- 
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der nonreducing conditions.  Coomassie brilliant  blue-stained gel 
of P~ is shown on the left. A, mAb 3A4; B, 5A2; C, 5C1; D, 5D3; 
E, 6D6; F, 8B3; G,  8D3; H, 9B5; I, 9D2. 
tions  suggested that the antibody binding  sites  on laminin 
were very near the center of the cross. However, this binding 
tended to obscure details, often resulting in a tangled appear- 
ance.  On the other hand,  mAbs 5A2, 5C1, and 5D3 bound 
at  sites  adequately  distant  from  the  center  of the  cross, 
thereby unequivocally locating their epitopes.  A  schematic 
diagram  summarizing  the binding  sites  for these  mAbs is 
shown in Fig.  8.  Hereafter,  mAbs 5A2 and 5C1  will be re- 
ferred  to  as  mAbs-SA~  and  -SA2,  respectively,  reflecting 
their localization to the short a_rms of laminin, and 5D3 will 
Figure  5.  Electron micrographs of rotary-shadowed  preparations 
consisting  of mAb 5A2 and intact laminin (top) and elastase-gen- 
erated fragments affinity isolated over a column of 5A2-Sepharose 
(bottom).  mAb 5A2 binds  to an internal  globular domain on the 
short arms of intact laminin (arrows) and to corresponding sites on 
the elastase  fragments  (arrowheads).  Scale bar,  100 nm. 
be referred to as mAb-LA, reflecting its binding to the end 
of the long arm. 
Imraunofluorescence  of Laminin with mAbs 
All  nine  of the  mAbs clearly  reacted  with  mouse  kidney 
tubular basement membranes (TBM) and glomerular mes- 
Figure 4.  Lanes 1 and 2 show SDS-PAGE of reduced laminin  and 
products  after  elastase  digestion  as  described  in  Materials  and 
Methods.  Relative  molecular weight  x  103 is shown on the left. 
(Lane 3) Prestained relative molecular weight standards transferred 
to nitrocellulose.  (Lane 4) mAb 5D3 binds to a single band on an 
electrobiot of the elastase  digest.  (Lanes 5 and 6) mAbs 5A2 and 
9D2 bind to several products in the elastase digest,  but these differ 
from that recognized by mAb 5D3.  (Lane 7) mAb 5D3 does not 
bind to elastase  fragments affinity  isolated  by mAb 5A2.  (Lane 8 
and 9) mAbs 5A2 and 9D2 bind to elastase  fragments affinity iso- 
lated by mAb 5A2. 
Figure 6. Micrographs ofmAb 5C1 and intact laminin (top) and the 
P1 fragments  obtained  by gel filtration  after pepsin digestion  (bot- 
tom).  MAb 5C1 binds to the short arms •18  nm from the center 
of the laminin cross (arrows) and the same binding site is seen on 
P1  fragments  (arrowheads).  Scale  bar,  100 nm. 
Abrahamson et al. Laminin Orientation in Renal Basement Membranes  3481 Figure 7. Micrographs ofmAb 5D3 and intact laminin (top) and the 
E8 fragment obtained after elastase digestion and mAb 5D3 affinity 
chromatography  (bottom). mAb 5D3 binds to an epitope located 
,~15 nm above the terminal  globular  domain  of the long arm of 
laminin  (arrows) and to the  same site on E8  fragments  (arrow- 
heads). Scale bar,  100 nm. 
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Figure 8.  Schematic diagram 
of iaminin  showing the loca- 
tions  of binding  sites for the 
mAbs. Epitopes for 5A2, 5C1, 
and  5D3  (arrowheads) were 
determined directly by rotary 
shadow EM with intact lami- 
nin  and  proteolytic  digests. 
Because  mAb  9D2  behaved 
exactly like 5A2 on immuno- 
blots,  we  consider  it  likely 
that 9D2 maps near the same 
site. Locations for the remain- 
ing mAbs were inferred from 
blots of digests. 
angial matrices as shown by immunofluorescence micros- 
copy on sections of unfixed tissues, but there were some vari- 
ations in labeling (Fig. 9).  mAbs 8B3 and 8D3 bound only 
to some TBM, whereas the other mAbs appeared to label all 
TBM uniformly (Fig. 9). We obtained identical immunofluo- 
rescence  results  when cryostat kidney  sections  from mice 
that had received intravenous injections of mAbs were la- 
beled  directly  with  anti-rat  IgG-fluorescein.  In  contrast, 
when cryostat sections from kidneys that had been fixed with 
2 % paraformaldehyde or the paraformaldehyde-lysine-peri- 
odate fixative were indirectly labeled, basement membrane 
fluorescence for all of the mAbs was either greatly dimin- 
ished or abolished. Mild fixation with 1% paraformaldehyde 
did  result  in  some basement membrane labeling,  but  the 
most intense  fluorescence was always obtained on unfixed 
sections. The antibodies were also positive on unfixed cryo- 
stat sections of mouse peripheral  nerve,  smooth,  skeletal, 
and cardiac muscle, and intestine, except for 8B3 and 8D3, 
which did not bind basement membranes in these sites (Fig. 
10).  In addition, attempts to "unmask" epitopes by pretreat- 
ment of cryostat sections  with acetic acid,  chondroitinase 
ABC, heparitinase, or heparinase failed to result in binding 
of 8B3 or 8D3 in these tissues. 
lmmunoelectron Microscopic Localization of  Laminin 
Two considerably different ultrastructural patterns of peroxi- 
dase  reaction  product  were  obtained  in  kidney  basement 
membranes after the intravenous injection of different con- 
jugates of monoclonal anti-laminin IgG-HRP. First,  mAb- 
LA (5D3) bound in irregular patterns to the lamina rara in- 
terna of the peripheral loop glomerular basement membrane 
(GBM) (Fig. 11). The amount of reaction product within pe- 
ripheral loop GBM was highly variable, ranging from spotty 
labeling as shown (Fig.  11) to no labeling. However, mesan- 
gial matrices, especially those areas immediately adjacent to 
mesangial cells, were consistently and densely labeled (Fig. 
12). The lamina rara beneath the parietal epithelium of Bow- 
man's capsule was specifically stained (Figs.  11 and 13) and 
dense labeling was also seen in the  lamina rara along the 
proximal TBM (Figs.  14,  a  and b).  Little or no staining of 
the lamina densa in the GBM, Bowman's capsule, or prox- 
imal TBM was obtained with mAb-LA (Figs.  11-14,  a  and 
b). By contrast, HRP reaction product was present through- 
The Journal of Cell Biology, Volume 109, 1989  3482 Figure 10.  Immunofluorescence micrographs ot cryostat sections 
taken of unfixed stomach smooth muscle (top), skeletal muscle (M) 
and peripheral nerve (N) (middle),  and cardiac muscle (bottom) 
labeled with antibodies shown. Except for 8B3 and 8D3, all mAbs 
labeled mouse muscle and peripheral nerve basement membranes. 
Scale bar in Top left, 40 ~tm. All other figures were taken at the same 
magnification. Scale bar in bottom right,  100 I~m. 
out the lamina densa as well as the lamina rara in the base- 
ment membranes of the distal tubule (Figs.  11  and  14 c). 
Results obtained with HRP conjugates prepared with mAbs 
3A4, SA~ (5A2), SA2 (5C1),  6D6, 8D3, 9B5, and 9D2 were 
essentially similar.  Within glomeruli, only occasional and 
nonlinear binding  was  seen  in  the  peripheral  loop GBM 
(Figs.  15 and 16), but all mAbs densely labeled the mesan- 
gial matrices (Fig.  15).  As seen previously with mAb-LA, 
these mAbs also did not bind to the lamina densa of that part 
of the GBM that reflected over the mesangial matrix. In con- 
trast to the dense staining seen with mAb-LA specifically in 
the lamina lucida of Bowman's capsule basement membrane 
(Figs.  11 and 13), these mAbs labeled Bowman's capsule in 
spotty patterns (Fig.  16).  A  similar spotty distribution was 
also seen in the TBM beneath the proximal tubule epithelium 
and discrete deposits of reaction product could often be de- 
tected in both the lamina rara and densa (Fig.  17 a). On the 
other hand,  a  dense,  apparently  even pattern of reaction 
product was seen throughout the lamina densa of the distal 
TBM (Fig.  17 b). Injections of 8B3-HRP resulted in appar- 
ently the same binding patterns as seen with these mAbs, but 
the peroxidase reaction product was much weaker in all loca- 
tions.  Perhaps the conjugation procedure affected the anti- 
gen-combining sites on mAb 8B3. Peroxidase reaction prod- 
uct was not present on the bases of foot processes or within 
the GBM, mesangial matrices, or other basement membranes 
in mice that received intravenous injections of control rat 
IgG-HRP (Fig.  18). 
Discussion 
Earlier immunofluorescence and immunoperoxidase studies 
have shown that various basement membranes are differen- 
tially immunoreactive to anti-laminin mAbs (25, 27, 29, 38, 
63).  In general, the previous immunoelectron microscopic 
reports have demonstrated that the relevant laminin epitopes 
are either present across the entire width of basement mem- 
branes or completely absent (29).  Using peroxidase-conju- 
gated mAbs mapped by rotary shadowing to different struc- 
tural domains of laminin, however, our findings are the first 
to show that separate epitopes can be localized specifically 
to discrete sites within basement membranes. 
On the basis of inhibition ELISAs, immunoprecipitation, 
electroblotting, and rotary shadowing of immune complexes, 
we conclude that the rat mAbs described here reacted specif- 
ically with mouse tumor laminin. Consistent with their sen- 
sitivities  to  aldehyde fixation,  the  epitopes  recognized by 
these antibodies were probably proteinaceous, because lami- 
nin secreted by tunicamycin-treated PYS cells was immuno- 
precipitated. Most of the mAbs immunoprecipitated laminin 
A  and  B  chains  and  mAb-LA  also  immunoblotted  both 
chains.  These results therefore indicate that  similar if not 
identical epitopes were present on different laminin polypep- 
tides.  Owing to the close sequence homology between the 
B1, B2, and A chains (24, 49, 53-55), this is perhaps not sur- 
prising  and  others  have  likewise  found that  anti-laminin 
mAbs bind laminin A and B chains (27, 47,  59). 
What do these experiments tell us about the molecular ar- 
chitecture of basement membranes? First, we interpret our 
immunoultrastructural  detection  of  rnAb-LA  specifically 
Figure 9. Immunofluorescence micrographs otcryostat sections taken from unfixed mouse kidneys labeled sequentially with rat anti-laminin 
mAbs and goat anti-rat IgG-fluorescein. a and b are labeled with mAbs SAt and LA, respectively, and show intense linear fluorescence 
of all TBM (arrowheads) and mesangial matrices of glomeruli (G). C shows labeling with mAb 8B3 where TBMs in some tubules are 
not labeled (arrows). Glomerular (G) labeling with mAb 8B3 is also relatively weaker than what is seen with mAbs SAI and LA. Scale 
bar,  100 txm. 
Abrahamson et al. Laminin Orientation in Renal Basement Membranes  3483 Figures 11-13. Electron micrograph of mouse kidney 3 h after intravenous injection with mAb-LA-HRP. Some peroxidase reaction product 
is seen within the lamina tara interna of the GBM. The innermost layer of Bowman's capsule basement membrane (BC) adjacent to the 
parietal epithelium (PE) is also specifically  labeled, whereas TBM beneath the distal tubule epithelium (DT) is stained across its full width 
(arrows). CL, capillary lumen; Po, podocyte; US, urinary space. Scale bar, 1 ~m. (Figure 12) Micrograph showing mesangial distribution 
of mAb-LA-HRP 3 h after injection. The matrix adjacent to mesangial cells (Me) is densely labeled. There is little or no binding of mAb-LA 
The Journal of Cell Biology,  Volume 109, 1989  3484 Figure 14. Micrographs showing the labeling  of TBM in different regions of the nephron by injections  of mAb-LA-HRE In the proximal 
convoluted tubule (a and b), mAb-LA localizes only to the lamina rara (arrows) immediately  beneath the basal labyrinth of  proximal tubule 
epithelial  cells (PT). The lamina densa of the TBM is unstained.  Note that there appears to be a small amount of reactivity  (arrowheads) 
in the lamina rara of the thin basement membrane beneath the endothelium (En) (b). Scale bar (a and b), 0.5/zm. In contrast, in the distal 
tubule (c), mAb-LA binds uniformly across the full thickness of the basement membrane beneath the distal tubule epithelium  (DT). Scale 
bar,  0.5/~m. 
within the lamina lucida of Bowman's capsule and the prox- 
imal  TBM to indicate  that the  long arms of at least  some 
laminin  molecules  are  present  directly  beneath  the  basal 
plasma membranes of kidney epithelial cells. Due to the pos- 
sibility that laminin assumes multiple orientations,  the long 
arms of other laminin molecules may extend in an opposite 
direction into the lamina densa. Epitopes for mAb-LA were 
not detected  in the  lamina densa in these basement mem- 
tO the lamina densa (arrows) of the GBM reflecting over the mesangial  matrix. Po, podocytes.  Scale bar,  1 #m. (Figure 13) Higher power 
view of Bowman's capsule showing in vivo labeling with mAb-LA-HRP. Only the innermost layer of  Bowman's capsule basement membrane 
is labeled  (arrows).  US,  urinary space; PE, parietal  epithelium.  Scale bar,  0.25 #m. 
Abrahamson et al. Laminin Orientation in Renal  Basement  Membranes  3485 Figures 15 and 16. Glomerulus from a mouse that received mAb SA~-HRP  3 h before fixation. Peroxidase reaction product is seen in ma- 
trices adjacent to mesangial cells (Me) but is generally absent in the peripheral loop GBM. CL, capillary lumen; RBC, erythrocyte; En, 
endothelium; Po, podoeyte; US, urinary  space. Scale bar, 5 ttm.  (Figure 16) Micrograph showing a general absence of binding of mAb 
SAt-HRP to the peripheral loop GBM and a spotty distribution of peroxidase reaction product across the full width of Bowman's capsule 
basement membrane (arrows). Small spots of reactivity are also seen in the proximal TBM (arrowheads). Po, podocyte foot processes; 
PE, parietal epithelium;  PT, proximal tubule epithelium.  Scale bar,  1 ~m. 
branes, however, perhaps because of masking by other com- 
ponents. Our results nevertheless indicate striking immuno- 
reactivity differences for laminin in different strata of certain 
basement  membranes.  Furthermore,  they  suggest  that  at 
least some normal epithelial cells may use the end of the long 
arm of laminin for basement membrane attachment in vivo. 
Additional  support  for this  possibility comes from recent 
studies showing that chymotrypsin-generated laminin flag- 
The Journal of Cell Biology, Volume 109,  1989  3486 Figure  17. Representative micrographs showing the distribution of mAbs against laminin short arms in TBM of different regions of the 
nephron. (a) Tangential  section across TBM of  proximal tubule (Par). Binding ofmAb 9D2-HRP to the TBM is seen as discrete, sometimes 
semiregular deposits of reaction product (arrows).  Scale bar, 1/zm. (b) In contrast, all mAbs bound apparently evenly across the full width 
of distal tubule (DT) basement membranes and spotty reaction patterns were not observed. Shown here is distribution of mAb-SA2-HRP. 
Scale bar,  1/zm. 
ments, which contain the terminal globule of the long arm 
and promote neurite outgrowth in culture, also mediate the 
attachment and spreading of a number of different nonneu- 
ronal cell lines in vitro (13).  Antisera directed specifically 
against the end of the long arm inhibits embryonic kidney 
epithelial cell polarization in vitro, further implicating a role 
for this domain of laminin in cell adhesion (34). In addition, 
recent studies have clearly demonstrated the specific binding 
of HT-1080 fibrosarcoma cells to native laminin via interac- 
tions with the long arm, E8 fragment (45). Because some 
previous investigations  with  polyclonal anti-laminin  anti- 
bodies localized laminin mainly to the laminae rarae of the 
GBM (12,  18), perhaps the polyspecific IgGs used in these 
earlier experiments were directed primarily against the end 
of long arm.  In contrast,  in the basement membranes be- 
neath the distal tubule epithelium, peroxidase reaction prod- 
uct from mAb-LA-HRP was  found throughout the lamina 
rata and lamina densa, reflecting a localization of the end of 
the long arm to both sites in this basement membrane. 
A clear interpretation of the results with antibodies that 
Abraharnson et al. Laminin  Orientation  in Renal Basement Membranes  3487 Figure 18. Glomerulus from a mouse that received an injection of control rat IgG-HRP 3 h before fixation. Reaction product is completely 
absent in GBM, mesangial matrices and Bowman's capsule (BC) basement membranes. CL, capillary lumen; En, endothelium; Me, mesan- 
gium; Po, podocyte. Scale bar, 5/zm. 
mapped near the center of the laminin cross, including mAb- 
SAt  and  -SA2, which bound on the  short arms,  is  much 
more difficult to reach. All of these mAbs immunolocalized 
specifically and intensely across the lamina densa of distal 
tubule basement membranes. On the other hand, because the 
epitopes for these same antibodies were scattered in discrete 
spots across the basement membranes of  the proximal tubule 
and Bowman's capsule, we conclude again that the molecular 
organization of  basement membranes in these latter sites was 
therefore different. The distribution of distinct deposits of 
peroxidase across the multilayered Bowman's capsule base- 
ment membrane (41) is particularly interesting in view of the 
finding that rnAb-LA bound only to the innermost layer im- 
mediately beneath the parietal epithelium.  The absence of 
labeling in any particular site could have been due to masking 
of epitopes by other components or to a change in confor- 
mation of laminin.  Nevertheless, whereas our results with 
mAb-LA demonstrated  immunoreactivity differences in  a 
vertical plane between the lamina rara and densa, our find- 
ings with these other mAbs are intriguing because they dem- 
onstrate that microdomains with different immunoreactivi- 
ties exist laterally within basement membranes. In addition, 
these immunolocalization results are noteworthy since earlier 
studies have shown that the pepsin resistant,  cross-shaped 
laminin P1 fragment mediates substrate adhesion for a num- 
ber of different tumor ceils and cell lines in vitro (40,  61). 
Further, various synthetic peptides corresponding to unique 
structural domains deduced from eDNA clones of the lami- 
nin B1 chain have been tested for cell binding activities. A 
sequence of five amino acids (YIGSR) that resides on the 
short arm of the B1 chain near the center of the cross, has 
been shown to promote tumor cell adhesion in vitro, and bind 
to a 67-kD laminin-binding protein isolated from tumor cell 
membranes (21, 22).  Consequently, one might predict that 
the lamina rara would be particularly enriched with the P1 
domain of laminin.  We recognize that, if kidney epithelial 
cells were indeed adhering to laminin via interactions with 
the P1 domain, some of  the epitopes for the mAbs would pos- 
sibly be obscured.  That none of the five different anti-P1 
mAbs  densely labeled the lamina  rara,  however, suggests 
that the PI domain was not abundantly present in this layer. 
Moreover, some anti-laminin mAbs that block the adhesion 
of melanoma cells to laminin in vitro have been shown by ro- 
tary shadowing to bind to a region of the long arm extending 
beneath the center of the cross (59). In addition, an integrin- 
like receptor protein for laminin has been isolated from hu- 
man glioblastoma cells that apparently does not interact with 
the YIGSR pentapeptide on the B1 chain of laminin (19), but 
may bind the RGD sequence in the A chain (55). This evi- 
dence, in conjunction with that discussed earilier on the abil- 
ity of the end of  the long arm of laminin to mediate cell adhe- 
sion, demonstrates that there are probably several distinct 
cell-binding regions on the laminin molecule and these seem 
to be distributed to different structural domains. 
We do not consider an absence of mAb-HRP immunoreac- 
tivity within a particular layer of basement membrane to be 
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agents for several reasons. First, we have previously shown 
that affinity purified, poiyclonal anti-laminin IgG-HRP, in 
the same concentrations as used here for the monoclonal- 
HRP conjugates, binds throughout the full thickness of all 
vascular and epithelial basement membranes in organs fed 
by fenestrated or sinusoidal capillary systems (63). Here we 
observed that mAb-HRP conjugates yielded substantially 
different distribution patterns in different basement mem- 
branes. Second, our immunoperoxidase localization studies 
were conducted after the in vivo administration of antibod- 
ies, and binding therefore took place in the absence of fixa- 
tives of any kind. Indeed, for mAb-LA to bind almost exclu- 
sively to the lamina rarae of basement membranes beneath 
the parietal epithelium of Bowman's capsule or to renal prox- 
imal TBMs in vivo, the lamina densae of these same mem- 
branes must first have been crossed. Epitopes for mAb-LA, 
if present at all, were therefore not exposed in the lamina 
densa of these basement membranes, Similarly, epitopes for 
all of the monoclonal antibodies in the present analysis were 
undetectable in the lamina densa of peripheral loop GBM. 
This result is interesting because the GBM originates during 
nephrogenesis by the "fusion" of a double basement mem- 
brane beneath the vascular endothelium and visceral epithe- 
lium, respectively (reviewed in reference 4). Perhaps certain 
epitopes on laminin are masked or removed during this fu- 
sion process, and we are presently examining these possibil- 
ities. 
Our mAb immunolocalization results partially agree with 
those obtained with polyclonal antibodies prepared against 
different structural domains of laminin. The latter studies 
have been conducted on mouse cornea and identify the center 
of the laminin cross primarily in the lamina densa and the 
end of the long arm mainly in the lamina rata (57).  Unlike 
our findings in the kidney, however, the end of the long arm 
is also seen at the interface between the lamina densa and un- 
derlying stroma in the cornea (57). Earlier studies have also 
shown that different mouse anti-laminin mAbs bind selec- 
tively to different human basement membranes. One appar- 
ently binds all epithelial, muscle, and peripheral nerve base- 
,ment membranes whereas another reacts with only some 
epithelial  and  vascular  endothelial  basement  membranes 
(38). Some of these antibodies have also delineated a change 
in laminin immunoreactivities with development: early em- 
bryonic basement membranes are negative but become pro- 
gressively positive with maturation (25). Similarly, two rat 
mAbs that bind different epitopes on mouse laminin B chains 
react in different patterns with basement membranes (29). 
One of these antibodies binds all kidney GBM and TBM, 
whereas another binds only the TBM beneath proximal con- 
voluted tubules and the thin and thick ascending segments of 
Henle's loop (29).  An analogous heterogeneity in mouse 
kidney basement membranes has been detected using immu- 
nofluorescence microscopy and anti-mouse tumor laminin 
mAbs (27). mAbs against a laminln homologue termed s-lam- 
inin also selectively stain certain basement membranes, par- 
ticularly those in synaptic clefts and GBM (28). A quantita- 
tive immunocytochemical study with polyclonal antibodies 
against laminin and other basement membrane proteins also 
shows a heterogeneous distribution of  these molecules in var- 
ious kidney basement membranes (12a).  The observed dif- 
ferences in immunoreactivities between various basement 
membranes indicates that some of the laminin epitopes are 
either absent in certain matrices, or masked by other compo- 
nents and therefore unavailable for binding. Our attempts to 
unmask cryptic epitopes with acid or enzymatic treatments 
were unsuccessful, however. 
We believe that there are only two possible explanations 
for the observations discussed here.  First,  the molecular 
orientation or intercalation of laminin into basement mem- 
branes may vary with location. Further, these variabilities 
could also exist in separate layers or planes within the same 
basement membrane. Alternatively, there may be several ge- 
netically distinct isoforms of laminin distributed to different 
locales (28).  In addition to the heterogeneity of laminin, 
selective binding to various basement membranes of mAbs 
against human collagen type IV (56) or uncharacterized hu- 
man basement membrane components (25) have been ob- 
served  previously.  Differences have  also been  seen  with 
polyclonal antibodies against the core protein of a rat base- 
ment membrane heparan sulfate proteoglycan (11). Together, 
all of the results strongly indicate that basement membranes 
in different locations are structurally unique. Whether these 
differences are related to the adhesive, permeability, or infor- 
mational properties of  basement membranes must now be es- 
tablished. 
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